Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP486570.RA7904UpCXk5__iiFQrK96oMlqer5F1APD1cFjNlXowLg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP486570.RA7904UpCXk5__iiFQrK96oMlqer5F1APD1cFjNlXowLg130_assertion type Assertion NP486570.RA7904UpCXk5__iiFQrK96oMlqer5F1APD1cFjNlXowLg130_head.
- NP486570.RA7904UpCXk5__iiFQrK96oMlqer5F1APD1cFjNlXowLg130_assertion description "[We conclude that TP53BP1-PDGFRB is a novel imatinib target in atypical chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP486570.RA7904UpCXk5__iiFQrK96oMlqer5F1APD1cFjNlXowLg130_provenance.
- NP486570.RA7904UpCXk5__iiFQrK96oMlqer5F1APD1cFjNlXowLg130_assertion evidence source_evidence_literature NP486570.RA7904UpCXk5__iiFQrK96oMlqer5F1APD1cFjNlXowLg130_provenance.
- NP486570.RA7904UpCXk5__iiFQrK96oMlqer5F1APD1cFjNlXowLg130_assertion SIO_000772 15492236 NP486570.RA7904UpCXk5__iiFQrK96oMlqer5F1APD1cFjNlXowLg130_provenance.
- NP486570.RA7904UpCXk5__iiFQrK96oMlqer5F1APD1cFjNlXowLg130_assertion wasDerivedFrom befree-20140225 NP486570.RA7904UpCXk5__iiFQrK96oMlqer5F1APD1cFjNlXowLg130_provenance.
- NP486570.RA7904UpCXk5__iiFQrK96oMlqer5F1APD1cFjNlXowLg130_assertion wasGeneratedBy ECO_0000203 NP486570.RA7904UpCXk5__iiFQrK96oMlqer5F1APD1cFjNlXowLg130_provenance.